http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999245-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18
filingDate 2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113999245-B
titleOfInvention Natural compound with anti-pancreatic cancer activity, isolation method and application thereof
abstract The invention discloses a natural compound with anti-pancreatic cancer activity. The compound is obtained through a series of extraction and separation from the ethyl acetate extraction phase of Qiang living, and includes a coumarin compound, three phenylpropanoid compounds compound and a lignin-like compound. The results of the anti-pancreatic cancer activity test show that the compound has a significant inhibitory effect on the proliferation of pancreatic cancer CAPAN-2, CFPAC-1, PANC-1, and SW1990 cells, indicating that it can significantly inhibit the proliferation of pancreatic cancer cells and has anti-pancreatic cancer properties. Potential role, in order to be used as an active ingredient in the preparation of a drug for the treatment of pancreatic cancer.
priorityDate 2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017147718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003128633-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453611334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448706207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449522968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452764334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261

Total number of triples: 50.